Merck Completes Acquisition of Harpoon Therapeutics, Inc.
HARPOON THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Harpoon Therapeutics, Inc. - HARP
Merck Buys Harpoon Therapeutics To Expand Its Oncology Portfolio
Shareholder Alert: Ademi LLP investigates whether Harpoon Therapeutics, Inc. has obtained a Fair Price in its transaction with Merck
HARP Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Harpoon Therapeutics, Inc. Is Fair to Shareholders
Why Is Harpoon Therapeutics (HARP) Stock Up 111% Today?
Merck to Buy Harpoon Therapeutics for $680 Million
Merck to buy Harpoon Therapeutics for $680 million
Merck to Acquire Harpoon Therapeutics, Further Diversifying Oncology Pipeline
Merck close to acquiring cancer specialist Harpoon Therapeutics
Merck in talks to buy Harpoon Therapeutics for around $700 mln - Bloomberg News
Harpoon Therapeutics Strengthens Leadership Team
Harpoon Therapeutics Abstract for HPN328 Accepted for Rapid Oral Presentation at the 2024 American Society of Clinical Oncology Genitourinary Cancers Symposium
Harpoon Therapeutics Presents HPN217 Phase 1 Clinical Data in Relapsed/Refractory Multiple Myeloma (RRMM) at ASH 2023 and Announces Selection of Recommended Phase 2 Dose (RP2D)
5 Small Drug Stocks to Buy on Hopes of Better Prospects in the New Year
Should You Buy Harpoon Therapeutics, Inc. (HARP) After Golden Cross?
Harpoon Therapeutics, Inc. (HARP) Upgraded to Strong Buy: What Does It Mean for the Stock?
Best Momentum Stock to Buy for December 5th
Is it a Good Idea to Invest in Harpoon (HARP) Stock Now?
Wall Street Analysts Believe Harpoon Therapeutics, Inc. (HARP) Could Rally 40.5%: Here's is How to Trade
Harpoon: HPN328 Data In 1st Half Of 2024 Makes This A Must Watch
New Strong Buy Stocks for November 21st
Fast-paced Momentum Stock Harpoon Therapeutics, Inc. (HARP) Is Still Trading at a Bargain
Wall Street Analysts See a 92.31% Upside in Harpoon Therapeutics, Inc. (HARP): Can the Stock Really Move This High?
New Strong Buy Stocks for November 14th
Harpoon Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Harpoon Therapeutics Abstract for HPN217 Accepted for Presentation at the 65th American Society of Hematology (ASH) Annual Meeting and Exposition
Harpoon Therapeutics stock soars on ‘promising' lung cancer drug results
Harpoon Therapeutics Announces Up to $150 Million Private Placement
Harpoon Therapeutics Announces Updated Interim Tolerability and Response Data from Phase 1/2 Clinical Trial of T Cell Engager HPN328 at ESMO Congress 2023
Harpoon Therapeutics to Host Webcast Reviewing HPN328 Interim Data Presented at ESMO Congress 2023 on October 23, 2023
Harpoon Therapeutics to Present Interim Tolerability and Response Data from Phase 1/2 Clinical Trial of T Cell Engager HPN328 at ESMO Congress 2023
Harpoon Therapeutics Presents HPN217 Interim Phase 1 Data at the IMS Annual Meeting
Harpoon Therapeutics Announces First Patients with Small Cell Lung Cancer Dosed in HPN328 Combination Cohort
Harpoon Therapeutics Provides an Update on the HPN217 Development and Option Agreement with AbbVie
Harpoon Therapeutics Abstract for HPN217 Accepted for Poster Presentation at the 20th International Myeloma Society Annual Meeting
Harpoon Therapeutics to Host KOL Event in Person and via Webcast on September 15, 2023
Harpoon Therapeutics to Participate in Two Upcoming Investor Conferences in September
Harpoon Therapeutics, Inc. (HARP) Beats Q2 Earnings and Revenue Estimates
Harpoon Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Harpoon Therapeutics to Participate in Two Upcoming Investor Conferences in August
Harpoon Therapeutics Appoints Haibo Wang as Senior Vice President of Business Development
Replicate Bioscience Appoints Rachael Lester as Chief Business Officer
3 Penny Stocks with Multibagger Potential for the Second Half of 2023
The 3 Most Undervalued Penny Stocks to Buy in February 2023
New Strong Buy Stocks for January 27th
Why Fast-paced Mover Harpoon Therapeutics, Inc. (HARP) Is a Great Choice for Value Investors
7 Stocks to Add to Your 10x Watchlist
Harpoon Therapeutics Remains Volatile After Promising News